Brielle Urciuoli

Ketamine, typically used to kickstart and maintain anesthesia use, could be an option for treating patients with ovarian cancer whose pain is difficult to treat.

An expert discusses tips on how patients with cancer can manage their "scanxiety."

Although JAK inhibitors are a proven effective treatment for patients with myelofibrosis, a type of myeloproliferative neoplasm (MPN), they may come with a severe downside; in particular, a 16-fold increase in the chance of developing a B-cell lymphoma, according to recent research published in the journal Blood.

The trial that led to national screening guidelines—which recommend screening based on age and smoking history—did not include fair representation from all racial/ethnic groups.

Surveillance of potentially cancerous skin lesions is key in early detection and treatment of the disease, which vastly improves outcomes.

Head and neck cancer survivors have about a 45% higher suicide ratio compared to all other cancers.

Two congressmen, who are also cancer survivors, proposed the Cancer Care Planning and Communications (CCPC) Act, which would create a Medicare billing code that would reimburse providers for their time and resources used to create survivorship care plans for patients with Medicare.

The Food and Drug Administration (FDA) approved Rubraca (rucaparib) as a maintenance therapy for women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy, according to Clovis Oncology, the company that manufactures the drug.

From diagnosis to post-treatment, survivors should have access to resources that help them navigate through their cancer journey.

A drug used to treat leukemia may also have potential in treating small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).

The BD Onclarity HPV Assay can detect up to 14 types of high-risk human papillomavirus (HPV) and identify genotypes that are strongly associated with cervical cancers.

Researchers have recently discovered that immunotherapy agents have potential to effectively treat desmoplastic melanoma, even though the dense tissue associated with this rare cancer would seem to preclude it.

Immunotherapy alone has not shown much success in treating ovarian cancer, despite success with other cancers, so researchers are now testing combinations of immunotherapy drugs with other agents to see if it enhances effectiveness.

Some underprivileged and minority groups are underrepresented in lung cancer clinical trials, which can affect how and whether they receive appropriate care.

Researchers conducted a meta-analysis of data from 61 studies to determine whether people who stay up all night for work have an increased risk of developing cancer.

Cisplatin, a platinum-based chemotherapy agent that is used to treat testicular cancer, non-small cell lung cancer, bladder cancer, cervical cancer, ovarian cancer and head and neck cancer, has been found to cause a significant amount of hearing loss in patients, according to a recent article published in Nature Communications.

NextSource Pharma has raised the price of oral chemotherapy agent lomustine (Gleostine) by 1400% since acquiring the drug, which is used to treat Hodgkin lymphoma and glioblastoma, from Bristol-Myers Squibb in 2013.

Carfilzomib, commonly used to treat patients with multiple myeloma, may lead to an increased risk of cardiovascular events.

Most people surveyed think that the cost of cancer care is too high, and some even reported taking action that could jeopardize the outcomes of their treatments to bring the cost down.

Aprepitant (Cinvanti), an injectable emulsion, is the second agent in just over two weeks to be approved by the Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea/vomiting (CINV).

Healthcare providers are quick to bring up side effects like nausea and neuropathy, but are far more apprehensive to talk about sexual issues.

The average cost of each hospital visit for CINV is over $15,000, according to a recent study.

Genes and gender may play a role in who is more likely to experience chemotherapy-related fatigue, according to a recent study.

A new tool is helping healthcare providers determine who will benefit from palliative care starting early in the course of their treatment for cancer, according to the authors of a pilot study whose results were presented Sept. 9, during the 2017 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.

Fertility preservation might be a bit more difficult for women with breast cancer who test positive for the BRCA gene mutation.

Socio-psychological factors have moved into the forefront of patients' concerns regarding chemotherapy effects, surpassing nausea and vomiting, which previously ranked as the top concern.

Although they bring devastation to the whole community hit, catastrophes introduce a new level of difficulty for patients who are being treated for cancer.

A California woman has been awarded $417 million after alleging that Johnson & Johnson’s talcum-based Baby Powder led to ovarian cancer. The jury award may be the largest yet concerning the product.

Artist Ryan Berardi’s work goes way beyond pretty pictures. In fact, his 3D animations of what can go wrong during chemotherapy paint a horrific scene.